Porous Microparticles for High Loading and Controlled Release

The patent applies preliminary action by incorporating the bioactive substance into the polymer matrix during the polymerization process itself, rather than attempting to load the substance after particle formation. The substance is mixed with the monomer solution before polymerization begins, ensuring maximum incorporation efficiency while maintaining process simplicity. This resolves the contradiction by performing the loading action in advance during a stage when the polymer matrix is still forming and accessible.

The patent employs porous polymeric particles with controlled pore structures that allow sustained release of bioactive substances while the porous nature prevents strong adhesive interactions with gastrointestinal mucus and cellular lining. The pore architecture enables diffusion-controlled release kinetics without requiring direct contact and adhesion to biological surfaces, thus resolving the contradiction between release control and adhesive limitations.

The patent applies local quality by creating a distributed network of pores throughout the polymer matrix rather than relying on a few large holes. This uniform porous structure provides numerous localized release pathways that collectively enable high protein release efficiency while maintaining structural integrity. The local porous architecture throughout the particle volume overcomes the limitation of low protein release from ultrasonically created holes.

The patent applies parameter changes by systematically controlling polymerization conditions including monomer concentration, cross-linker ratio, temperature, and reaction time to achieve narrow particle size distribution while preserving bioactivity. By optimizing these parameters, the process produces uniform particles that deliver bioactive substances effectively without the size variability and bioactivity loss seen in conventional systems.